Angiotech Seeks Partner For Stalled Vascular Wrap R&D Program
This article was originally published in The Gray Sheet
Executive Summary
Combination product developer Angiotech is looking for someone to help fund its stalled drug-eluting Vascular Wrap R&D program as part of a broader effort to return to profitability by year-end